Details for New Drug Application (NDA): 083889
NDA 083889 describes METHAMPEX, which is a drug marketed by Teva and is included in one NDA. Additional details are available on the METHAMPEX profile page.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 083889
| Tradename: | METHAMPEX |
| Applicant: | Teva |
| Ingredient: | methamphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083889
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
